Typically, activated B-cell-like (ABC) DLBCL shows chronic active B-cell receptor (BCR) signaling and MYD88 signaling due to recurrent genetic mutations involving CD79A/B and MYD88, which eventually leads to constitutive activation of NF-κB [5]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.